Skyward Specialty Insurance (SKWD) reports earnings tomorrow: what to expect

Skyward Specialty Insurance (SKWD) will report earnings after market close on Thursday. Last quarter, it beat revenue expectations with $489.5M, up 53% YoY. Analysts expect 30.8% YoY revenue growth this quarter. The stock is up 10.3% over the last month, with an average price target of $70.73.

Original reporting
Published Nov 4, 2026, 3:32 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 4:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Skyward Specialty Insurance (SKWD) reports earnings tomorrow: what to expect — source image
Decision brief

The 30-second read

$SKWDNeutralMed
01

Why it matters

Traders can use the cited consensus growth rate and the company’s historical tendency to meet revenue estimates to frame scenarios for the after-hours reaction and implied volatility into the print.

02

Market read

This is a pre-earnings positioning brief for SKWD, highlighting consensus revenue growth and recent estimate stability.

03

What to watch

The article emphasizes revenue growth and estimate reconfirmations but does not detail loss ratios, reserve development, or guidance specifics, which often drive the largest post-earnings moves for insurers.

Relevance 4/10Novelty 4/10Timing: ahead of Thursday after-market-close earnings

Background

The article previews Skyward Specialty Insurance’s upcoming earnings, referencing last quarter’s revenue beat and the current quarter’s consensus growth expectation.

Company-level read

Ticker impact

$SKWDNeutralMedium confidence
Context

Skyward Specialty Insurance (NASDAQ: SKWD) reports earnings Thursday after market close, with the article citing revenue growth expectations and recent estimate reconfirmations.

Expected impact

Likely volatility into the print, with upside if revenue and net premiums earned beat expectations and downside if growth or profitability disappoints.

Evidence & confidence

The piece is a pre-earnings setup, not the earnings release itself, but it provides consensus growth expectations and notes the company’s tendency to meet revenue estimates.

Market effects

A beat or miss at a specialty P&C insurer can influence read-through sentiment for underwriting momentum and premium growth expectations across the group.

Primarily US-focused, with limited direct regional spillover beyond US insurance sentiment.

Low global relevance; any impact is mainly through US specialty insurance risk appetite.

Counterpoint

Recent strength and analyst price targets may already be priced in; if results merely meet expectations, the stock could still sell off on lack of upside surprise.

Key entities

  • Skyward Specialty Insurance

    US specialty insurance provider scheduled to report earnings Thursday after market close.

  • Assurant

    Peer cited as having reported Q3 results with revenue growth and an estimate beat.

  • Markel Group

    Peer cited as having reported Q3 revenues above estimates and a post-results stock move.

Related articles

$SKWDHighAI 8/10

Raymond James reiterates Strong Buy on Skyward Specialty stock

Raymond James reiterated a Strong Buy rating and $75.00 price target for Skyward Specialty Insurance Group (NASDAQ:SKWD), citing strong value and growth prospects. The stock has risen 39% in six months. Q3 2026 net investment income increased 54% YoY to $34 million. Management prioritizes debt repayment over share buybacks. Raymond James raised its 2026 EPS estimate to $5.10. Skyward reported Q3 EPS of $1.28, beating estimates by 42.2%, with revenue at $501.77 million.

$SKWDMed

Jefferies raises Skyward Specialty Insurance stock price target to $64

Jefferies increased its price target for Skyward Specialty Insurance (NASDAQ:SKWD) to $64, maintaining a Hold rating. The firm cited the company's diversification and attractive valuation, but noted rising competition. Skyward reported Q3 2026 earnings of $1.28 per share, exceeding estimates, with revenue of $501.77 million. The stock declined due to competitive pressures and lack of 2027 guidance.

$SKWDHighAI 8/10

Skyward (SKWD) Q3 2026 Earnings Call Transcript

Skyward (SKWD) reported Q3 2026 earnings with operating income of $58M ($1.28 per diluted share) and 9M operating income of $175M. Gross written premiums rose 9% to $803M, with fee-generating premiums up 18% to $517M. Combined ratio was 89.9%, and operating return on equity exceeded 20%. Skyward Specialty saw 10% premium growth, while Apollo's premiums increased 3%, with fee income up 18%.

$SKWDMed

Skyward Specialty Insurance Group Q3 Earnings Call Highlights

Skyward Specialty Insurance Group reported a 13% rise in net earned premiums for the first nine months, with Q3 combined ratio at 88.3. Lower dairy and livestock coverage uptake and treaty year adjustments affected growth. Apollo's gross written premiums increased 3%, with fee-generating premiums up 18%. The company launched new initiatives and expects to provide 2027 guidance in Q4. Book value per share rose 15% to $28.74, with net investment income up 54%.

$SKWDMed

Skyward: Q3 Earnings Snapshot

Skyward Specialty Insurance Group (SKWD) reported Q3 profit of $49.8M, or $1.09 per share, beating analyst estimates of $1.22 per share. Adjusted earnings were $1.28 per share. Revenue was $455.3M, missing expectations of $507.3M.